Annals of Surgical Oncology

, Volume 1, Issue 2, pp 99–104

Variables related to risk of recurrence in rectal cancer without lymph node metastasis

  • Hiroyuki Ogiwara
  • Toshio Nakamura
  • Shozo Baba
Article

Abstract

Background: There has been recent interest in the use of local excision for rectal cancer under consideration of patient's quality of life. However, local excision of the primary tumor does not remove the areas of lymphatic spread. Therefore, the decision to use this procedure must be considered carefully.

Methods: The authors retrospectively analyzed 142 patients who underwent radical resection of rectal cancer without lymph node metastasis in order to define the risk factors for recurrence. The macroscopic and microscopic pathological characteristics, immunohistochemical staining for p53, and DNA ploidy pattern of the primary tumor were examined as potential predictors of recurrence.

Results: The rates for 5-year disease-free survival, local control, freedom from distant metastasis, and overall survival in these 142 patients were 87%, 93%, 93%, and 91%, respectively. Factors related to recurrence and prognosis included the depth of tumor invasion, vascular/lymphatic involvement, tumor differentiation, and tumor size. However, p53 staining and DNA ploidy pattern were not useful indicators.

Conclusions: Our findings suggest that adjunctive radiotherapy and chemotherapy should be considered for patients who have rectal cancer without lymph node metastasis in the following situations: tumor invasion of the serosa, vascular/lymphatic involvement, moderately differentiated adenocarcinoma, and lesions >2 cm in diameter. Local excision should not be used in these situations, even if there are no lymph node metastases.

Key Words

Rectal cancer Risk factors for recurrence p53 staining DNA ploidy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hojo K. Anastomotic recurrence after sphincter-saving resection for rectal cancer.Dis Colon Rectum 1986;29:11–14.PubMedGoogle Scholar
  2. 2.
    Pollet WG, Nicholls RJ. The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum.Ann Surg 1983;198:159–63.Google Scholar
  3. 3.
    Hojo K, Sawada T, Moriya Y. An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy.Dis Colon Rectum 1989;32:128–33.PubMedGoogle Scholar
  4. 4.
    Ziv Y, Ben-Baruch D, Waizer A, Flex D, Wolloch Y. Local recurrence after low anterior resection using the EEA stapling device.Dis Colon Rectum 1988;31:945–7.PubMedGoogle Scholar
  5. 5.
    Vlasak JW, Wagner D, Passaro E, Wilson S. Local recurrence after curative resection of rectal cancer: a comparison of low anterior resection and abdominoperineal resection.J Surg Oncol 1989;41:236–9.PubMedGoogle Scholar
  6. 6.
    Colombo P, Foglieni CLS, Morone C. Analysis of recurrence following curative low anterior resection and stapled anastomoses for carcinoma of the middle third and lower rectum.Dis Colon Rectum 1987;30:457–64.PubMedGoogle Scholar
  7. 7.
    Graaf PW, Roussel JG, Gorizak E, Hart GAM, Jongman A, Van Slooten E. Early-stage rectal cancer: electrofulguration in comparison to abdominoperineal extirpation or low-anterior resection.J Surg Oncol 1985;29:123–8.PubMedGoogle Scholar
  8. 8.
    Madden JL, Kandalaft S. Electrocoagulation as a primary curative method in the treatment of carcinoma of the rectum.Surg Gynecol Obstet 1984;157:164–79.Google Scholar
  9. 9.
    Brodsky JT, Richard G, Cohen AM, Minsky BD. Variables correlated with the risk of lymph node metastasis in early rectal cancer.Cancer 1992;69:322–6.PubMedGoogle Scholar
  10. 10.
    Graham RA, Gamsey L, Jessup JM. Local excision of rectal carcinoma.Am J Surg 1990;160:306–12.PubMedGoogle Scholar
  11. 11.
    Biggers OR, Beart RW, Ilstrup DM. Local excision of rectal cancer.Dis Colon Rectum 1986;29:374–7.PubMedGoogle Scholar
  12. 12.
    Hager T, Gall FP, Hermanek P. Local excision of cancer of the rectum.Dis Colon Rectum 1983;26:149–51.PubMedGoogle Scholar
  13. 13.
    Baily HR, Huval W, Max E, Smith KW, Butts DR, Zamora LF. Local excision of carcinoma of the rectum for cure.Surgery 1992;111:555–61.Google Scholar
  14. 14.
    Hojo K, Vernava AM III, Sugihara K, Katsumata K. Preservation of urine voiding and sexual function after rectal cancer surgery.Dis Colon Rectum 1991;34:532–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Willett C, Lewandrowski K, Donnelly S, Shellito PC, Convery K, Eliseo R, Compton CC. Are there patients with stage I rectal carcinoma at risk for failure after abdominoperineal resection?Cancer 1992;69:1651–5.PubMedGoogle Scholar
  16. 16.
    Dukes CE, Bussey HJR. The spread of rectal cancer and its effect on prognosis.Br J Cancer 1958;12:309–20.PubMedGoogle Scholar
  17. 17.
    Kaplan EL, Meier P. Nonparametric estimation for incomplete observations.J Am Stat Assoc 1958;53:457–81.Google Scholar
  18. 18.
    Colton T.Statistics in medicine. Boston, MA: Little Brown, 1974.Google Scholar
  19. 19.
    Banks L, Matelashewski G, Crawford L. Isolation of human-p53 specific monoclonal antibodies and their use in the studies of human p53 expression.Eur J Biochem 1986;159:529–31.CrossRefPubMedGoogle Scholar
  20. 20.
    Hedrey D, Friedlander M, Taylor I. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.Cytometry 1985;6:327–33.Google Scholar
  21. 21.
    Stearns MW, Sternberg SS, DeCosse JJ. Treatment alternatives: localized rectal cancer.Br J Surg 1985;72:694–7.Google Scholar
  22. 22.
    Minsky BD, Rich T, Recht A, Harvey W, Miles C. Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer.Cancer 1989;63:1421–9.PubMedGoogle Scholar
  23. 23.
    Rosenthal SA, Yeung RS, Weese JL, Eisenberg BL, Hoffman JP, Coia LR, Hanks GE. Conservative management of extensive low-lying rectal carcinomas with transanal local excision and combined preoperative and postoperative radiation therapy.Cancer 1992;69:335–41.PubMedGoogle Scholar
  24. 24.
    Pahlman L, Glimelius B, Graffman S. Pre- versus postoperative radiotherapy in rectal carcinoma: an interim report from a randomized multicentre trial.Br J Surg 1985;72:961–6.PubMedGoogle Scholar
  25. 25.
    Minsky BD, Kemeny N, Cohen AM, Enker WE, Kelsen DP, Reichman B, Saltz L, et al. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.Cancer 1991;67:2859–66.PubMedGoogle Scholar
  26. 26.
    Miyahara M, Saito T, Kakatani K, Sato K, Kuwahara A, Shimoda K, Kobayashi M. Clinical significance of ras p21 overexpression for patients with an advanced colorectal cancer.Dis Colon Rectum 1991;34:1097–102.CrossRefPubMedGoogle Scholar
  27. 27.
    Miller F, Heimann T, Quish A, Pyo DJ, Szporn A, Martinelli G, Fasy TM. ras and c-myc protein expression in colorectal carcinoma.Dis Colon Rectum 1992;35:430–5.CrossRefPubMedGoogle Scholar
  28. 28.
    Sugio K, Ishida T, Yokoyama H, Inoue T, Sugimachi K, Sasazuki T. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.Cancer Res 1992;52:2903–6.PubMedGoogle Scholar
  29. 29.
    Sun XF, Wingren S, Cartensen JM, Stal O, Hatschek T, Boeryd B, Nordenskoeld B, et al. ras p21 expression in relation to DNA ploidy, s-phase fraction and prognosis in colorectal adenocarcinoma.Eur J Cancer 1991;27:1646–9.PubMedGoogle Scholar
  30. 30.
    Iwaya K, Tsuda H, Hiraide H, Tamaki K, Tamakuma S, Fukutomi T, Mukai K, et al. Nuclear p53 immunoreaction associated with poor prognosis of breast cancer.Jpn J Cancer Res 1991;82:835–40.PubMedGoogle Scholar
  31. 31.
    Baker S, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53.Science 1990;249:912–5.PubMedGoogle Scholar
  32. 32.
    Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerasegamma.Nature 1987;326:515–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Dean PA, Vernava AM. Flow cytometric analysis of DNA content in colorectal carcinoma.Dis Colon Rectum 1992;35:95–102.CrossRefPubMedGoogle Scholar
  34. 34.
    Yonemura Y, Ooyama S, Sugiyama K, Kamata T, De Aretxabala X, Kimura H, Kosaka T, et al. Retrospective analysis of the prognostic significance of DNA ploidy patterns and s-phase fraction in gastric carcinoma.Cancer Res 1990;50:509–14.PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 1994

Authors and Affiliations

  • Hiroyuki Ogiwara
    • 1
  • Toshio Nakamura
    • 1
  • Shozo Baba
    • 1
  1. 1.Second Department of SurgeryHamamatsu University School of MedicineHamamatsuJapan

Personalised recommendations